TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group
Journal article published in 2017 by
Chiara Cremolini 
,
Federica Marmorino,
Fotios Loupakis,
Gianluca Masi ,
Carlotta Antoniotti,
Lisa Salvatore ,
Marta Schirripa,
Luca Boni,
Vittorina Zagonel,
Sara Lonardi,
Giuseppe Aprile,
Emiliano Tamburini ,
Vincenzo Ricci,
Monica Ronzoni,
Filippo Pietrantonio
and other authors.
,
Federica Marmorino,
Fotios Loupakis,
Gianluca Masi ,
Carlotta Antoniotti,
Lisa Salvatore ,
Marta Schirripa,
Luca Boni,
Vittorina Zagonel,
Sara Lonardi,
Giuseppe Aprile,
Emiliano Tamburini ,
Vincenzo Ricci,
Monica Ronzoni,
Filippo Pietrantonio
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 